Effects of Pelvic Floor Training in Male Chronic Pelvic Pain, Correlation Between Subjective and Objective Outcomes

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-12-01

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this randomized controlled study is to establish the long-term effect of pelvic floor re-education using biofeedback and home training for men with chronic pelvic pain. The main questions it aims to answer are if pelvic floor re-education using bio-feedback and home training will give a long-lasting improvement in symptoms, assessed with a validated symptom score (the National Institute of Health - Chronic Prostatitis Symptom Index) and if an improvement in symptoms can be correlated to objective measurements of pelvic floor function. Participants will be asked to do pelvic floor exercises daily during six months with additional sessions of bio-feedback training. The control group will have no changes in their on-going treatment for their chronic pelvic pain and will be offered to enter the treatment group after six months.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Pelvic Floor Muscle Training With and Without Biofeedback in Women With Stress Urinary Incontinence

NCT02275728

Menopause Urinary Incontinence, Stress

UNKNOWN NA

Outpatient Biofeedback in Addition to Home Pelvic Floor Muscle Exercises

NCT02851719

Urinary Incontinence, Stress

COMPLETED NA

Vibrator Use to Improve Sexual and Pelvic Floor Function Among Urogynecology Patients

NCT06677541

Pelvic Floor Dysfunction Sexual Dysfunction Female Vibrator

RECRUITING NA

Clinical Efficacy of Changing the InterStim® Parameters in Patients With Interstitial Cystitis/Painful Bladder Syndrome

NCT01312259

Painful Bladder Syndrome Interstitial Cystitis Pelvic Floor; Insufficiency +3 more

UNKNOWN PHASE4

HOme PElvic Floor Improvement Trainer Trial

NCT06909539

Pelvic Pain Pelvic Floor Dysfunction Voiding Dysfunction

NOT_YET_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

At baseline all included study subjects will fill in a validated symptom score, the National Institute of Health - Chronic Prostatitis Symptom Index (NIH-CPSI) and have an assessment of their pelvic floor muscles and undergo a urodynamic evaluation.

The intervention group will perform short daily session of pelvic floor muscle training at home during six months in combination with four bio-feedback sessions during the first months. The study subjects will receive an individual instruction based on the pelvic floor assessment from the baseline visit. The study subjects will report their training in a digital diary.

A reevaluation will be done at three, six and twelve months. At six and 12 months repeating the baseline tests. At three months a renewed assessment of muscle function and the NIH-CPSI questionnaire.

The control group will be instructed not to engage in any new treatment for their chronic pelvic pain during the study period. After the six months evaluation all participants in the control group will be offered to be enrolled in the treatment group, with the same set-up and follow-up as the treatment group.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Pelvic Pain Syndrome Chronic Prostatitis With Chronic Pelvic Pain Syndrome Chronic Prostatitis Pelvic Floor; Relaxation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

A randomized controlled single blinded clinical study with a study period of 12 months from inclusion until completion. The study subjects are then randomly assigned in a 1:1 ratio either to treatment or control group. After 6 months the study subjects in the control group are offered to be included in the intervention group.

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Investigators

The interpreter of the urodynamic evaluations will be blinded regarding intervention/control group

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Pelvic floor muscle re-education

Intervention with pelvic floor re-education using bio-feedback and home training for 6 months, with a follow up visit after an additional period of 6 months

Group Type EXPERIMENTAL

Pelvic floor re-education using bio-feedback and home training

Intervention Type OTHER

Pelvic floor re-education using bio-feedback and home training

Standard Care

No intervention during 6 months after inclusion. After the 6 month follow-up evaluation the study subjects are offered to participate in the interventional arm.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Pelvic floor re-education using bio-feedback and home training

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Men over the age of 18, residents in Sweden, diagnosed with Chronic Primary Pelvic Pain Syndrome (CPPPS) according to the International Statistical Classification of Diseases and Related Health Problems (ICD-10) (N41.1 (chronic prostatitis), N41.9 (Inflammatory disease of prostate, unspecified), N50.8F (Chronic Pelvic Pain Syndrome in men)

Exclusion Criteria

* Cancer in the abdomen or pelvic organs (current or previous)
* Congenital anomalies affecting the pelvic region (Bladder exstrophy, Myelomeningocele etc.)
* Transsexual male, (i.e. at birth biologically female)
* Diseases affecting the nerve function to the pelvic and/or lower extremities, other disease or ongoing treatment that could have an impact on the outcome of the study.
* Incapability to participate in testing or follow training instructions due to mental incapacity, language difficulties etc.

Minimum Eligible Age

18 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No